Back to Search
Start Over
The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.
- Source :
- BMC Cancer; 15, no 468 (2015); ISSN: 1471-2407
- Publication Year :
- 2015
-
Abstract
- HER2 is a well-established prognostic and predictive factor in invasive breast cancer. The role of HER2 in ductal breast carcinoma in situ (DCIS) is debated and recent data have suggested that HER2 is mainly related to in situ recurrences. Our aim was to study HER2 as a prognostic factor in a large population based cohort of DCIS with long-term follow-up.
Details
- Database :
- OAIster
- Journal :
- BMC Cancer; 15, no 468 (2015); ISSN: 1471-2407
- Notes :
- application/pdf, English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1023421191
- Document Type :
- Electronic Resource